Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Change in Inventory (2016 - 2023)

iBio (IBIO) has disclosed Change in Inventory for 6 consecutive years, with -$43000.0 as the latest value for Q1 2023.

  • On a quarterly basis, Change in Inventory fell 103.31% to -$43000.0 in Q1 2023 year-over-year; TTM through Jun 2023 was $1.0 million, a 73.79% decrease, with the full-year FY2023 number at $1.0 million, down 73.79% from a year prior.
  • Change in Inventory was -$43000.0 for Q1 2023 at iBio, up from -$79000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.4 million in Q4 2021 to a low of -$639000.0 in Q1 2021.
  • A 4-year average of $374181.8 and a median of $228000.0 in 2020 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: skyrocketed 1144.44% in 2021, then crashed 105.65% in 2022.
  • iBio's Change in Inventory stood at $228000.0 in 2020, then soared by 513.6% to $1.4 million in 2021, then tumbled by 105.65% to -$79000.0 in 2022, then soared by 45.57% to -$43000.0 in 2023.
  • Per Business Quant, the three most recent readings for IBIO's Change in Inventory are -$43000.0 (Q1 2023), -$79000.0 (Q4 2022), and $1.1 million (Q3 2022).